参考文献/References:
[1] Wu JJ,Kavanaugh A,Lebwohl MG,et al. Psoriasis and metabolic syndrome:implications for the management and treatment of psoriasis[J]. J Eur Acad Dermatol Venereol,2022,36(6):797-806.[2] Kapniari E, Papadimitriou P, Dalamaga M, et al. Investigating the link between psoriasis and cardiovascular disease: current evidence, therapeutic implications and perspectives[J].Curr Vasc Pharmacol, 2020,18(6):592-609.[3] Patrick MT,Li Q,Wasikowski R,et al. Shared genetic risk factors and causal association between psoriasis and coronary artery disease[J]. Nat Commun,2022,13(1):6565. [4] Weber B, Merola JF, Husni ME,et al. Psoriasis and cardiovascular disease:novel mechanisms and evolving therapeutics[J]. Curr Atheroscler Rep,2021,23(11):67.[5] Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases:Epidemiology[J]. J Am Acad Dermatol,2017,76(3):377-390.[6]李慧贤,胡丽,郑焱,等.基于全球疾病负担(GBD)大数据的中国银屑病流行病学负担分析[J]. 中国皮肤性病学杂志,2021,35(4):386-392.[7]Ahlehoff O,Gislason GH,J?gensen CH,et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke:a Danish Nationwide Cohort Study[J]. Eur Heart J,2012,33(16):2054-2064. [8]Ahlehoff O,Gislason G,Lamberts M,et al. Risk of thromboembolism and fatal stroke in patients with psoriasis and nonvalvular atrial fibrillation:a Danish nationwide cohort study[J]. J Intern Med,2015,277(4):447-455.[9]Rhee TM,Lee JH,Choi EK,et al. Increased risk of atrial fibrillation and thromboembolism in patients with severe psoriasis:a nationwide population-based study[J]. Sci Rep,2017,7(1):9973.[10]Bang CN,Okin PM,K?er L,et al. Psoriasis is associated with subsequent atrial fibrillation in hypertensive patients with left ventricular hypertrophy:the Losartan Intervention For Endpoint study[J]. J Hypertens,2014,32(3):667-672. [11]Yang HC,Poly TN,Islam MM,et al. Increased risk of atrial fibrillation in patients with psoriasis:a meta-analysis of observational studies[J]. Indian J Dermatol Venereol Leprol,2023,89(1):18-24.[12]Gao N,Kong M,Li X,et al. The association between psoriasis and risk of cardiovascular disease:a Mendelian randomization analysis[J]. Front Immunol,2022,13:918224. [13]Packer M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium[J]. J Am Coll Cardiol,2018,71(20):2360-2372. [14]Bai F,Zheng W,Dong Y,et al. Serum levels of adipokines and cytokines in psoriasis patients:a systematic review and meta-analysis[J]. Oncotarget,2017,9(1):1266-1278.[15]Mehta NN,Teague HL,Swindell WR,et al. IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesis[J]. Sci Rep,2017,7(1):13831.[16]Stefano P,?loria O,?rancesco M. Psoriasis and cardiometabolic diseases:shared genetic and molecular pathways[J]. Int J Mol Sci,2022,23(16):9063. [17]Yang C,Wang X,Guo Y,et al. Beneficial effect of edoxaban on preventing atrial fibrillation and coagulation by reducing inflammation via HBG1/HBD biomarkers[J]. Front Pharmacol,2023,13:904317.[18]Cohen S,Barer F,Itzhak I,et al. Inhibition of IL-17 and IL-23 in human keratinocytes by the A3 adenosine receptor agonist piclidenoson[J]. J Immunol Res,2018:2310970.[19]Glover BM, Hong KL, Dagres N, et al. Impact of body mass index on the outcome of catheter ablation of atrial fibrillation[J]. Heart,2019,105(3):244-250.[20]Strisciuglio T,Di Gioia G,Chatzikyriakou S,et al. Left atrial volume computed by 3D rotational angiography best predicts atrial fibrillation recurrence after circumferential pulmonary vein isolation[J]. Int J Cardiovasc Imaging,2018,34(3):337-342.[21]Chelu MG,King JB,Kholmovski EG,et al. Atrial fibrosis by late gadolinium enhancement magnetic resonance imaging and catheter ablation of atrial fibrillation:5-year follow-up data[J]. J Am Heart Assoc,2018,7:e006313. [22]Packer M. Effect of catheter ablation on pre-existing abnormalities of left atrial systolic,diastolic,and neurohormonal functions in patients with chronic heart failure and atrial fibrillation[J]. Eur Heart J,2019,40(23):1873-1879.[23]Lee MP,Desai RJ,Jin Y,et al. Association of ustekinumab vs TNF inhibitor therapy with risk of atrial fibrillation and cardiovascular events in patients with psoriasis or psoriatic arthritis[J]. JAMA Dermatol,2019,155(6):700-707.[24]Lin Yee C,?ntonio LP,?yotr G,et al. P wave parameters and indices:a critical appraisal of clinical utility,challenges,and future research—A consensus document endorsed by the international society of electrocardiology and the international society for holter and noninvasive electrocardiology[J]. Circ Arrhythm Electrophysiol,2022,15(4):e010435.[25]Y?d?? E, Günay N, Bayam E,et al. Relationship between paroxysmal atrial fibrillation and a novel electrocardiographic parameter P wave peak time[J]. J Electrocardiol,2019,57:81-86. [26]Ocak M, Tascanov MB. Clinical value of the combined use of P-wave dispersion and troponin values to predict atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation[J]. Rev Port Cardiol (Engl Ed),2021,40(9):679-684. [27]Akamatsu K,Ito T,Miyamura M,et al. Usefulness of tissue Doppler-derived atrial electromechanical delay for identifying patients with paroxysmal atrial fibrillation[J]. Cardiovasc Ultrasound,2020,18(1):22.[28]Uijl DW, Gawrysiak M, Tops LF, et al. Prognostic value of total atrial conduction time estimated with tissue Doppler imaging to predict the recurrence of atrial fibrillation after radiofrequency catheter ablation[J]. Europace,2011,13(11):1533-1540. ?29]Koca H, Demirtas AO, Kaypakl?O, et al. Decreased left atrial global longitudinal strain predicts the risk of atrial fibrillation recurrence after cryoablation in paroxysmal atrial fibrillation[J]. J Interv Card Electrophysiol,2020,58(1):51-59. ?30]Bacaksiz A,Erdogan E,Tasal A,et al. Electrocardiographic P-wave characteristics in patients with psoriasis vulgaris[J]. Ups J Med Sci,2013,118 (1):35-41.[31]Tasal A,Guvenc TS,Kul S,et al. Atrial conduction abnormalities in patients with psoriasis vulgaris[J]. Kardiol Pol,2015,73(8):637-643.[32]Duman H,Dilek N,Demirelli S,et al. The relationship between total atrial conduction time and left atrial global strain in patients with psoriasis vulgaris[J]. Arch Med Sci,2019,15(4):865-871.[33]Yi P,Jiang J,Wang Z,et al. Comparison of mean platelet volume (MPV) and red blood cell distribution width (RDW) between psoriasis patients and controls:A systematic review and meta-analysis[J]. PLoS One, 2022,17(2):e0264504.[34]George B,?onstantinos PL,?onstantinos V,et al.?imple hematological predictors of AF recurrence in patients undergoing atrial fibrillation ablation[J]. J Geriatr Cardiol,2019,16(9):671-675. [35]Gul SS,Gozke E. Mean platelet volume in patients with acute ischemic stroke with nonvalvular atrial fibrillation[J]. Clin Lab,2018,64(11).DOI:10.7754/Clin.Lab.2018.180543.[36]Conic RR,Damiani G,Schrom KP,et al.Psoriasis and psoriatic arthritis cardiovascular disease endotypes identified by red blood cell distribution width and mean platelet volume[J]. J Clin Med,2020,9(1):186.[37]Cataldi C,Mari NL,Lozovoy MAB,et al. Proinflammatory and anti-inflammatory cytokine profiles in psoriasis:use as laboratory biomarkers and disease predictors[J]. Inflamm Res,2019,68(7):557-567.[38]Yamaguchi N, Okumura Y, Watanabe I, et al. Clinical implications of serum adiponectin on progression of atrial fibrillation[J]. J Arrhythm,2017,33(6):608-612.?39]Hao Y, Zhu YJ, Zou S, et al.?etabolic Syndrome and Psoriasis:Mechanisms and Future Directions[J]. Front Immunol,2021,12:711060. DOI:10.3389/fimmu.2021.711060.[40]Rosen?NAL,L?up EH,Richardson C,et al. Exploring disease comorbidities and temporal disease progression of psoriasis:an observational,retrospective,multi-database,cohort study[J]. Br J Dermatol,2023,188(3):372-379.[41]Jafferany M,Patel A. Understanding psychocutaneous disease:psychosocial & psychoneuroimmunologic perspectives[J]. Int J Dermatol,2020,59(1):8-15.[42]Luiza MJ,Rafa?C,Alina B,et al. The brain-skin axis in psoriasis—Psychological,psychiatric,hormonal,and dermatological aspects[J]. Int J Mol Sci,2022,23(2):669. [43]Yang H, Zheng J. Influence of stress on the development of psoriasis[J]. Clin Exp Dermatol,2020,45(3):284-288. ?44]Pondeljak N, Lugovi?Mihi?L. Stress-induced interaction of skin immune cells,hormones,and neurotransmitters[J]. Clin Ther,2020,42(5):757-770.[45]Wu H,?i C,Li B,et al. Psychological factors and risk of atrial fibrillation:a meta-analysis and systematic review[J]. Int J Cardiol,2022,362:85-92. [46]Egeberg A,Khalid U,Gislason GH,et al. Association between depression and risk of atrial fibrillation and stroke in patients with psoriasis:a Danish nationwide cohort study[J]. Br J Dermatol,2015,173(2):471-479. [47]Armstrong AW, Read C. Pathophysiology,clinical presentation,and treatment of psoriasis:a review[J]. JAMA,2020,323(19):1945-1960.?48]Coates LC, Merola JF, Grieb SM,et al. Methotrexate in psoriasis and psoriatic arthritis[J]. J Rheumatol Suppl,2020,96:31-35.[49]Gawa?o M, Balsam P, Lodziński P,et al. Cardiac arrhythmias in autoimmune diseases[J].Circ J,2020,84(5):685-694. [50]Marty FM, Ljungman P, Chemaly RF,et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation[J]. N Engl J Med,2017,377(25):2433-2444.[51]Ghoreschi K, Balato A, Enerb?k C,et al. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis[J]. Lancet,2021,397(10275):754-766.[52]Singh R, Koppu S, Perche PO,et al. The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications[J]. Int J Mol Sci,2021,22(23):12793. [53]Nogueira M, Puig L, Torres T. JAK inhibitors for treatment of psoriasis:focus on selective TYK2 inhibitors[J]. Drugs,2020,80(4):341-352.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(2):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(2):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(2):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(2):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(2):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]